首页> 外文期刊>Theriogenology >In vitro bovine embryo production in a synthetic medium: Embryo development, cryosurvival, and establishment of pregnancy
【24h】

In vitro bovine embryo production in a synthetic medium: Embryo development, cryosurvival, and establishment of pregnancy

机译:在合成培养基中体外牛胚的产生:胚胎发育,冷冻存活和妊娠建立

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to develop an in vitro embryo culture medium without either fetal calf serum or BSA, using various growth factors and cytokines (GFs-CYKs; IGF-I, IGF-II, bFGF, LIF, GM-CSF, TGF-beta 1, and PDGF-BB), and other molecules with surfactant and embryotrophic properties, such as recombinant albumin (RA) and hyaluronan (HA). The first part of the study was dedicated to define the best combination of GFs-CYKs + RA + HA for optimal embryonic development. Next, we compared development rates and embryo quality (inner cell mass [ICM]-to-total cell number [TCN] ratio), and postthaw survival and hatching rates using this synthetic medium (T1) and a control medium: synthetic oviduct fluid + BSA + ITS (insulin, transferrin, and selenium). The blastocyst rates were significantly higher with T1 than those with the control at 7 and 8 days after fertilization. There was no significant difference in TCN or the ICM/TCN ratio between the two treatments. Survival and hatching rates 48 hours after thawing were similar for both treatments. Finally, nine embryo transfers were conducted using fresh and previously frozen Day-7 blastocysts to evaluate the in vivo viability of embryos produced in this synthetic medium; four gestations were obtained from six fresh embryos and one gestation from three frozen embryos. In conclusion, the fetal calf serum and BSA-free medium, supplemented with GFs-CYKs + RA + HA, improved embryo development and gave comparable ICM/TCN ratios and postthaw survival rates to the control with BSA. Fresh and frozen embryos produced in this medium are viable for embryo transfer. This fully synthetic method of embryo culture is a useful means of reducing the risk of disease transmission via embryo transfer. (C) 2015 Elsevier Inc. All rights reserved.
机译:这项研究的目的是使用各种生长因子和细胞因子(GFs-CYKs; IGF-I,IGF-II,bFGF,LIF,GM-CSF,TGF)开发一种既没有胎牛血清也没有牛血清白蛋白的体外胚胎培养基。 -β1和PDGF-BB)以及其他具有表面活性剂和胚胎营养特性的分子,例如重组白蛋白(RA)和透明质酸(HA)。研究的第一部分致力于定义GFs-CYKs + RA + HA的最佳组合,以实现最佳的胚胎发育。接下来,我们比较了使用这种合成培养基(T1)和对照培养基:合成输卵管液+的发育速度和胚胎质量(内部细胞质量[ICM]与总细胞数[TCN]的比率),以及解冻后的存活率和孵化率。 BSA + ITS(胰岛素,转铁蛋白和硒)。受精后7天和8天,T1的胚泡率显着高于对照组。两种治疗之间的TCN或ICM / TCN比没有显着差异。解冻后48小时的存活率和孵化率与两种处理方法相似。最后,使用新鲜的和先前冷冻的Day-7胚泡进行了9次胚胎移植,以评估在这种合成培养基中产生的胚胎的体内存活力。从六个新鲜胚胎中获得四个妊娠,从三个冷冻胚胎中获得一个妊娠。总之,胎牛血清和不含BSA的培养基补充了GFs-CYKs + RA + HA,可改善胚胎发育,并提供与BSA对照组相当的ICM / TCN比和解冻后存活率。在这种培养基中产生的新鲜和冷冻胚胎对于胚胎移植是可行的。这种完全合成的胚胎培养方法是降低通过胚胎移植传播疾病的风险的有用方法。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号